Viewing nowPitasthan Tablet 1 mg (Pitavastatin Calcium Hydrate)
Pitavastatin Calcium Hydrate 1.102mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

MFDS item code 202102918 · Approved 2021.04.05 · Insurance code 649702670
Improvement of hypercholesterolemia (including familial hypercholesterolemia in children) and mixed dyslipidemia
This medication is used as an adjunct to dietary therapy to lower total cholesterol, LDL-cholesterol, apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing the good cholesterol known as HDL-cholesterol. It is particularly applicable to pediatric patients aged 10 to 16 years with heterozygous familial hypercholesterolemia, helping to safely manage high cholesterol levels. The drug is more effective in patients with a family history or risk factors for early cardiovascular disease, thus playing an important role in improving cardiovascular health. Overall, this treatment is used to improve blood lipid levels and reduce the risk of cardiovascular disease occurrence.
Patients receiving this medication before and during treatment must follow a standard cholesterol-lowering diet. 1. Adjunct to diet therapy to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels and increase HDL cholesterol in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial, Fredrickson type lla) and mixed dyslipidemia (Fredrickson type llb) The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. The dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and patient response, and the therapeutic effect of this medication is maintained with continued administration.
Ages 10 to 16 years: Take 1 milligram of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 2 milligrams daily.
This medication should not be administered to patients with known allergies to certain ingredients. Patients with active liver disease or persistently elevated liver function test results should also avoid this medication. Patients with severe liver disorders or biliary obstruction should not be given this drug, nor should it be used in patients taking cyclosporine. Individuals with myopathy, pregnant women, women who may become pregnant, and nursing mothers should not use this medication. It should also not be administered to patients with genetic issues such as lactose intolerance. Patients with impaired renal function or a history of liver disorders should use this medication with caution. In particular, co-administration with fibrates or niacin should be avoided due to the risk of muscle damage and worsening renal function. Caution is also advised when used in elderly or pediatric patients, particularly in cases of myasthenia. Unusual symptoms such as muscle pain, weakness, abdominal pain, rash, itching, etc. may occur while taking this medication, so it is essential to consult a doctor immediately if any symptoms arise. Regular liver function tests should be performed, and if liver abnormalities are found, the treatment should be discontinued. This medication can cause serious muscle damage known as rhabdomyolysis; therefore, if muscle-related symptoms arise, stop taking it immediately. There are many drug interactions, particularly with cyclosporine, fibrates, niacin, erythromycin, etc., thus increasing the risk of renal function deterioration and muscle damage; caution should be exercised. Pregnant women or those who may become pregnant should not use this medication, and it should be discontinued immediately if pregnancy is confirmed during treatment. In children, this medication should be administered with great care only under the guidance of a specialist for the treatment of familial hypercholesterolemia, and safety in children under the age of 10 has not been established. This medication should be kept out of the reach of children, stored in its original container to prevent misuse or degradation in quality.
Abdominal pain, rash, malaise, paralysis, itching, increased γ-GT, elevated plasma creatine phosphokinase levels, increased serum ALT, increased serum AST, headache, myalgia, rhabdomyolysis, weakness, elevated myoglobin in blood and urine, liver dysfunction, jaundice, thrombocytopenia, urticaria, erythema, angioedema, increased bilirubin, elevated cholinesterase, increased ALP, elevated LDH, stiffness, drowsiness, insomnia, heaviness in the head, dizziness, dry mouth, dyspepsia, abdominal bloating, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastric discomfort, diarrhea, granulocytopenia, leukopenia, eosinophilia, leukocytosis, increased globulin, positive Coombs test, anemia, increased frequency of urination, elevated BUN, increased serum creatinine, decreased aldosterone, increased aldosterone, elevated adrenocorticotropic hormone, increased cortisol, decreased testosterone, muscle cramps, myalgia, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, hematuria, increased uric acid levels, increased serum potassium and phosphorus, altered taste, discolored urine, malaise, positive antinuclear antibody test, hair loss, sleep disorders, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, myasthenia gravis, ocular myasthenia, facial edema, arm swelling, hypersensitivity, paresthesia, increased blood pressure, chest discomfort, weakness, nausea
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that protects from light, and it is safe to keep at room temperature between 1 to 30 degrees Celsius. Storing it this way can maintain the drug's effectiveness and prevent degradation.
White round film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPitavastatin Calcium Hydrate 1.102mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

Pitavastatin Calcium Hydrate 1mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Pitavastatin Calcium Hydrate 2mg
Tablet · Prescription medication
JW Pharmaceutical Corporation
Pitavastatin Calcium 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.